Burkitt-like lymphoma with 11q aberration is characterized by pathological features and gene expression profile resembling those of Burkitt lymphoma but lacks the rearrangement and carries an 11q-arm aberration with proximal gains and telomeric losses. Whether this lymphoma is a distinct category or a particular variant of other recognized entities is controversial. To improve the understanding of Burkitt-like lymphoma with 11q aberration we performed an analysis of copy number alterations and targeted sequencing of a large panel of B-cell lymphoma-related genes in 11 cases. Most patients had localized nodal disease and a favorable outcome after therapy. Histologically, they were high grade B-cell lymphoma, not otherwise specified (8 cases), diffuse large B-cell lymphoma (2 cases) and only one was considered as atypical Burkitt lymphoma. All cases had a germinal center B-cell signature and phenotype with frequent LMO2 expression. The patients with Burkitt-like lymphoma with 11q aberration had frequent gains of 12q12-q21.1 and losses of 6q12.1-q21, and lacked common Burkitt lymphoma or diffuse large B-cell lymphoma alterations. Potential driver mutations were found in 27 genes, particularly involving , , , , and However, , , or mutations were absent in all cases. These results suggest that Burkitt-like lymphoma with 11q aberration is a germinal center-derived lymphoma closer to high-grade B-cell lymphoma or diffuse large B-cell lymphoma than to Burkitt lymphoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717587 | PMC |
| http://dx.doi.org/10.3324/haematol.2018.207928 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant.
Pathol Res Pract
December 2024
Section of Pathology, Department of Medical Biotechnology, University of Siena, Siena, Italy. Electronic address:
Various aggressive lymphomas entities have been associated with immunodeficiency. To provide further evidence that also MYC-negative high-grade B-cell (formerly Burkitt-like) lymphoma with 11q aberrations comprises an immunodeficiency-related subtype, we here conducted a comprehensive pathological and genetic workup of a 25-year-old patient with this type of lymphoma and simultaneous papillary renal cell carcinoma. The patient developed both malignancies following extensive childhood immunosuppression and a kidney transplant.
View Article and Find Full Text PDFNon-Hodgkin's primary lymphoma involving the genitourinary tract: histopathological experience from two tertiary hospitals, Western region, Saudi Arabia.
Am J Clin Exp Urol
October 2024
Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center Jeddah, Saudi Arabia.
Article Synopsis
- The study focuses on primary lymphoid neoplasms in the urinary tract and male genital organs, which are rare and make up less than 5% of extranodal lymphomas.
- Researchers analyzed cases diagnosed from 2005 to 2020, examining pathology slides from 11 patients, predominantly middle-aged, finding a female predominance in urinary bladder and ureter lymphomas.
- The findings confirm that diffuse large B-cell lymphoma (DLBCL) is the most common subtype, but emphasize the importance of thorough classification and diagnosis using techniques like immunohistochemistry to accurately identify various lymphoma types.
[Clinicopathological characteristics of angioimmunoblastic T-cell lymphoma with B-cell proliferation or neoplasms].
Zhonghua Bing Li Xue Za Zhi
July 2024
Department of Pathology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Article Synopsis
- - The study examines angioimmunoblastic T-cell lymphoma (AITL) cases with a focus on their clinical, pathological, and immunophenotypic characteristics, as well as the differential diagnosis involving B-cell proliferation or neoplasms.
- - Eight cases from a hospital in China were analyzed, revealing one case of AITL with diffuse large B-cell lymphoma (DLBCL) and seven cases of AITL with B-cell proliferation, with an average patient age of 58 years.
- - The findings highlight distinct histological features and tumor behavior in AITL with B-cell involvement, suggesting that a combination of clinical, morphological, and molecular analyses is essential for accurate diagnosis.
Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Pediatr Blood Cancer
August 2024
The Royal Marsden Hospital, Sutton, London, UK.
Article Synopsis
- Monomorphic post-transplant lymphoproliferative disorder (mPTLD) is a significant health risk after solid organ transplants, with challenges in balancing treatment intensity and risks like infection and organ rejection.* -
- A study analyzed 56 children with mPTLD treated with low-intensity therapies in the UK and Spain, finding that 92.8% survived for one year, despite 78.6% presenting with advanced disease.* -
- The results indicate that R-COP, a low-dose chemotherapy, is an effective initial treatment, with escalation to more aggressive approaches beneficial for those who do not adequately respond.*
Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
PLoS Pathog
April 2024
Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisconsin, United States of America.
Epstein-Barr virus (EBV) is an important cause of human lymphomas, including Burkitt lymphoma (BL). EBV+ BLs are driven by Myc translocation and have stringent forms of viral latency that do not express either of the two major EBV oncoproteins, EBNA2 (which mimics Notch signaling) and LMP1 (which activates NF-κB signaling). Suppression of Myc-induced apoptosis, often through mutation of the TP53 (p53) gene or inhibition of pro-apoptotic BCL2L11 (BIM) gene expression, is required for development of Myc-driven BLs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!